General Cell Collection Detail
orders accepted or email / fax
your order to us.
General Cell Collection: DH82
|Cell Line Name:||DH82|
|Cell Line Description:||Derived from a ten year old male golden retriever with malignant histiocytosis. The cells have a macrophage-like morphology and are able to phagocytose latex particles. They are positive for Fc-gamma receptors and are negative for Fc-mu and C3b receptors. DH82 cells do not produce IL-1.|
|Subculture Routine:||Cells are semi-adherent, i.e. some cells grows in suspension, whilst most attach to the surface and may flatten. Attached cells should be removed with 0.02% EDTA. Split sub-confluent cultures (70-80%) i.e. seeding at 2-4x10,000 cells/cm²; 5% CO2; 37°C.|
|Culture Medium:||EMEM (EBSS) + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 15% Foetal Bovine Serum (FBS) (Heat Inactivated).|
|Depositor:||Obtained from ATCC|
|References:||In Vitro Cell Dev Biol 1988;24:223-229|
|Additional Bibliography:||Not specified|
|Patents:||This material is cited in a US and/or other Patent and may not be used to infringe parent claims. US Patent No. 5,192,679|
|Research Council Deposit:||No|
The HPA Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by HPA Culture Collections are accurate, HPA Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and HPA Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.
Cultures supplied by HPA Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.